COVID

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Oct 9, 2022

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

ipharmaservices

Jan 7, 2022

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

ipharmaservices

Jan 3, 2022

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

ipharmaservices

Nov 21, 2021

WHO granted EUL to Covaxin; acclaims easy storage requirement

WHO granted EUL to Covaxin; acclaims easy storage requirement

WHO granted EUL to Covaxin; acclaims easy storage requirement

ipharmaservices

Nov 3, 2021

United Kingdom COVID19 News | Has Britain reached herd immunity?

United Kingdom COVID19 News | Has Britain reached herd immunity?

United Kingdom COVID19 News | Has Britain reached herd immunity?

ipharmaservices

May 11, 2021

France COVID-19 Updates | COVID-19 News in Europe

France COVID-19 Updates | COVID-19 News in Europe

France COVID-19 Updates | COVID-19 News in Europe

ipharmaservices

May 4, 2021

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

ipharmaservices

Mar 29, 2021

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

ipharmaservices

Oct 9, 2020

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

ipharmaservices

Sep 26, 2020

Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

ipharmaservices

Sep 24, 2020

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

ipharmaservices

Sep 9, 2020

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA extended emergency use authorization of Veklury to all hospitalized patients

ipharmaservices

Aug 30, 2020

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

ipharmaservices

Aug 27, 2020

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

ipharmaservices

Aug 18, 2020

Gilead’s Veklury received conditional marketing authorization from the European Commission

ipharmaservices

Jul 3, 2020

Janssen’s COVID-19 vaccine trial to begin in second half of July

ipharmaservices

Jun 11, 2020

Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit

ipharmaservices

Jun 7, 2020

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

ipharmaservices

Jun 3, 2020

EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation

ipharmaservices

May 17, 2020

bottom of page